The	O
differential	O
regulation	O
of	O
human	O
telomerase	O
reverse	O
transcriptase	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
may	O
contribute	O
to	O
the	O
clinically	O
more	O
aggressive	O
behavior	O
of	O
p63	B-Cancer
-	I-Cancer
positive	I-Cancer
breast	I-Cancer
carcinomas	I-Cancer
.	O

p63	O
,	O
a	O
p53	O
homologue	O
,	O
is	O
a	O
myoepithelial	B-Cell
cell	I-Cell
marker	O
in	O
the	O
normal	O
mammary	B-Organ
gland	I-Organ
but	O
p63	B-Cell
-	I-Cell
positive	I-Cell
neoplastic	I-Cell
cells	I-Cell
may	O
be	O
found	O
in	O
up	O
to	O
11	O
%	O
of	O
invasive	B-Cancer
breast	I-Cancer
carcinomas	I-Cancer
.	O

This	O
study	O
aims	O
to	O
verify	O
the	O
relationship	O
between	O
p63	O
expression	O
and	O
several	O
clinicopathological	O
features	O
and	O
tumor	B-Cancer
markers	O
of	O
clinical	O
significance	O
in	O
breast	B-Cancer
pathology	I-Cancer
including	O
key	O
regulators	O
of	O
the	O
cell	B-Cell
cycle	O
,	O
oncogenes	O
,	O
apoptosis	O
-	O
related	O
proteins	O
,	O
metalloproteinases	O
and	O
their	O
inhibitors	O
.	O

Immunohistochemistry	O
with	O
27	O
primary	O
antibodies	O
was	O
performed	O
in	O
100	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
samples	B-Cancer
of	O
invasive	B-Cancer
ductal	I-Cancer
carcinomas	I-Cancer
.	O

p63	B-Cell
-	I-Cell
positive	I-Cell
cells	I-Cell
were	O
found	O
in	O
16	O
%	O
of	O
carcinomas	B-Cancer
.	O

p63	B-Cancer
-	I-Cancer
positive	I-Cancer
carcinomas	I-Cancer
were	O
poorly	O
differentiated	O
,	O
hormone	O
receptor	O
-	O
negative	O
neoplasms	B-Cancer
with	O
a	O
high	O
proliferation	O
rate	O
.	O

p63	O
also	O
correlated	O
with	O
advanced	O
pathological	O
stage	O
,	O
tumor	B-Cancer
size	O
,	O
and	O
the	O
expression	O
of	O
human	O
telomerase	O
reverse	O
transcriptase	O
(	O
hTERT	O
)	O
,	O
tissue	O
inhibitor	O
of	O
matrix	O
metalloproteinase	O
1	O
(	O
TIMP1	O
)	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
.	O

The	O
expression	O
of	O
TIMP1	O
suggests	O
that	O
the	O
anti	O
-	O
proteolytic	O
stimuli	O
may	O
be	O
preponderant	O
in	O
p63	B-Cancer
-	I-Cancer
positive	I-Cancer
carcinomas	I-Cancer
.	O

hTERT	O
activity	O
is	O
associated	O
with	O
nodal	B-Cancer
metastases	I-Cancer
and	O
cellular	B-Cell
proliferation	O
.	O

VEGF	O
regulates	O
angiogenesis	O
,	O
which	O
is	O
also	O
a	O
fundamental	O
event	O
in	O
the	O
process	O
of	O
tumor	B-Cancer
growth	O
and	O
metastatic	O
dissemination	O
.	O

Thus	O
,	O
the	O
differential	O
regulation	O
of	O
hTERT	O
and	O
VEGF	O
in	O
p63	B-Cancer
-	I-Cancer
positive	I-Cancer
breast	I-Cancer
carcinomas	I-Cancer
may	O
contribute	O
to	O
the	O
clinically	O
more	O
aggressive	O
behavior	O
of	O
these	O
neoplasms	B-Cancer
.	O

